Pfizer’s Chantix Move Seen as Positive Signal for Achieve Life Sciences
Analysts say Pfizer listing Chantix on TrumpRx may support Achieve Life Sciences and boost confidence in cytisinicline’s approval prospects.
Feed↓
/ What's going on?
Filter:
Hellman & Friedman Eyes Acquisition of Bill Holdings Amid Activist Pressure
Private equity firm Hellman & Friedman is in talks to buy Bill Holdings Inc., a business payments company valued at $4.2 billion, as activist investors push for change.
Trump Team Eyes Antitrust Probe Into Major US Homebuilders
The Trump administration is considering investigating large homebuilders over potential price coordination and supply restrictions as housing affordability worsens across America.
Hims vs. Novo Nordisk: Why the Pharma Giant Might Avoid a Legal Fight
Hims is selling a $49 copycat of Novo Nordisk's $149 weight-loss pill, but legal experts say Novo may avoid court battles due to risks of setting dangerous precedents.
Apple Bucks Big Tech's AI Spending Frenzy While Cloud Backlogs Hit $1.1 Trillion
While Amazon, Google, Meta, and Microsoft pour record billions into AI infrastructure, Apple takes a different approach—and Big Tech cloud backlogs reach unprecedented levels.
Under Armour Beats Expectations, Raises 2026 Outlook Despite Tariff Headwinds
Under Armour (UA) stock jumps 11% as Q3 results exceed forecasts. Company raises annual profit outlook while navigating tariffs and business transformation with premium product focus.